GlassScriptPhysician profile
Kuo S Ooi
NPI 1598775421
$15,560.59
in general payments reported to CMS, 2019-2025
62 companies · $2,138 in 2025
The $2,138 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,692 · 2020: $1,910 · 2021: $2,419 · 2022: $2,402 · 2023: $2,665 · 2024: $2,336 · 2025: $2,138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,139.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,256.23 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,757.21 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $1,434.17 | 2019-2025 | Breztri, Fasenra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,135.98 | 2019-2025 | Jardiance, Spiriva Respimat |
| Pfizer INC. | $1,026.20 | 2019-2025 | |
| Novo Nordisk INC | $962.95 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $946.00 | 2019-2025 | Evenity, Prolia, Repatha |
| Lilly USA, LLC | $785.58 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Merck Sharp & Dohme LLC | $349.05 | 2019-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Allergan, INC. | $342.56 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $329.39 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $299.46 | 2019-2024 | Xifaxan |
| Astellas Pharma US INC | $284.21 | 2023-2025 | Veozah |
| Kowa Pharmaceuticals America, INC. | $252.28 | 2019-2023 | Seglentis, Livalo |
| Takeda Pharmaceuticals U.S.A., INC. | $239.33 | 2019-2023 | Trintellix |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $199.29 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $177.21 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $175.93 | 2021 | |
| Abbott Laboratories | $172.08 | 2021-2025 | Freestyle Libre 3, Id Now Instrument |
| Boston Scientific Corporation | $165.89 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Janssen Pharmaceuticals, INC | $154.27 | 2019-2024 | Spravato |
| Sanofi-Aventis U.S. LLC | $127.17 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $116.34 | 2024-2025 | Voquezna |
| Amarin Pharma, INC. | $112.51 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $109.71 | 2021-2023 | |
| Sanofi Pasteur INC. | $95.22 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $88.72 | 2020-2023 | Eliquis |
| Collegium Pharmaceutical, INC. | $81.93 | 2023-2024 | Xtampza |
| Bausch Health US, LLC | $80.17 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $79.69 | 2025 | Amvuttra |
| Hologic Sales and Service, LLC | $74.53 | 2019-2024 | Aptima |
| Eisai INC. | $71.59 | 2020-2025 | |
| Ibsa Pharma INC. | $69.97 | 2021-2022 | |
| Antares Pharma, INC. | $68.06 | 2020 | |
| Neos Therapeutics, LP | $67.41 | 2019 | |
| Cranial Technologies, INC | $54.98 | 2024-2025 | Doc Band |
| Qiagen, LLC | $53.11 | 2021-2023 | |
| Pacira Therapeutics, INC. | $53.10 | 2019 | |
| Dexcom, INC. | $52.14 | 2023-2024 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $52.11 | 2020 | |
| Esperion Therapeutics, INC. | $51.16 | 2020-2021 | |
| Daiichi Sankyo INC. | $50.76 | 2025 | Injectafer |
| Therapeuticsmd, INC. | $50.74 | 2020-2022 | |
| Seqirus USA INC | $48.47 | 2020-2023 | Fluad Quadrivalent, Flucelvax Quadrivalent |
| Alexion Pharmaceuticals, INC. | $43.19 | 2023 | Strensiq |
| Xeris Pharmaceuticals, INC. | $37.75 | 2023-2024 | Keveyis, Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $33.06 | 2021 | |
| Dermira, INC. | $31.23 | 2020 | |
| Verity Pharmaceuticals INC. | $30.22 | 2025 | Tlando |
| Idorsia Pharmaceuticals US INC | $29.62 | 2023 | Quviviq |
| Bioventus LLC | $24.43 | 2020 | |
| Ironwood Pharmaceuticals, INC | $18.80 | 2023 | Linzess |
| Acerus Pharmaceuticals Corporation | $17.24 | 2021 | |
| Fidia Pharma USA INC. | $16.87 | 2024 | Hymovis |
| Halozyme INC | $16.86 | 2023 | |
| Currax Pharmaceuticals LLC | $16.41 | 2025 | Contrave |
| Corium, LLC | $16.20 | 2022 | |
| Silk Road Medical, INC. | $16.07 | 2019 | |
| Becton, Dickinson and Company | $15.83 | 2021 | |
| Stryker Corporation | $14.89 | 2024 | Augment Injectable |
| Adlon Therapeutics L.P. | $13.74 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kuo Ooi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.